First PCSK9 Outcome Trial Results Pushed Back To 2017
Uptake of the new drugs likely to lag without strong outcomes data. Uptake of the new drugs likely to lag without strong outcomes data.Uptake of the new drugs likely to lag without strong outcomes data. –Uptake of the new drugs likely to lag without strong outcomes data. There’s probably nothing more eagerly awaited in cardiovascular...Click here to continue reading...
Source: CardioBrief - Category: Cardiology Authors: Larry Husten Tags: People, Places & Events Policy & Ethics Prevention, Epidemiology & Outcomes Amgen CVOT Fourier PCSK9 Repatha Source Type: blogs